Maarten Huisman

Maarten Huisman has extensive experience in the field of pharmaceuticals and biotechnology. Maarten is currently working as a DMPK Lead and R&D Director at UCB, where they are involved in the discovery and development of protein degraders, ASO-conjugates, and Abs. Maarten'srole emphasizes ADME and PK-PD studies, along with shaping the target product profile.

Prior to their current position, Maarten worked as a Senior Consultant at 3D-PharmXchange and as an R&D Leader at Oystershell Laboratories, focusing on medical device development and compliance with regulatory requirements.

Maarten also served as an R&D Director at 2 Bridge CVBA, providing scientific support and project leadership services in the pharmaceutical and health product development sector.

Maarten's experience with The Janssen Pharmaceutical Companies of Johnson & Johnson includes roles as a Pharmacokinetics, Dynamics and Metabolism scientist, ADME-responsible for a colorectal cancer project, and Principal Scientist. Maarten was also a DMPK In Vivo lab team leader and a DMPK In vitro lab team leader during their time at Janssen Pharmaceutica.

Before their industry roles, Maarten worked as a Post-Doc researcher at the University of Amsterdam.

Overall, Maarten Huisman has a diverse background and expertise in various aspects of pharmaceutical research and development.

Maarten Huisman obtained their PhD in Pharmaceutical Sciences from Utrecht University from 1998 to 2003. Prior to that, they completed their MSc in Biology, specializing in Molecular and Medical Genetics, at the University of Groningen from 1993 to 1998. In addition to their formal education, Maarten also obtained various certifications from LinkedIn, including courses on Microsoft 365 New Features, Windows migration, audit and due diligence, high-stakes communication, executive influence, building resilience, presentation design, remote leadership skills, webcam video presence, personal branding, learning R, and the basics of Scrum.